• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同浓度KH902滴眼液对碱烧伤诱导的角膜新生血管的抑制作用。

The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn.

作者信息

Wu Yan, Xue Chunyan, Lu Yan, Huang Zhenping

机构信息

Department of Ophthalmology, Jinling Medical School of Nanjing Medical University; Department of Ophthalmology, Jinling Hospital, Nanjing 210002, Jiangsu Province, PR China.

Department of Ophthalmology, Jinling Hospital, Nanjing 210002, Jiangsu Province, PR China.

出版信息

Indian J Ophthalmol. 2017 Nov;65(11):1127-1132. doi: 10.4103/ijo.IJO_339_17.

DOI:10.4103/ijo.IJO_339_17
PMID:29133637
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5700579/
Abstract

PURPOSE

The aim of this study was to evaluate the inhibitory effect of different concentrations of KH902 eye drops on rabbit corneal neovascularization (CNV) induced by alkali burn.

METHODS

Forty-eight adult rabbits were randomized into four groups after alkali burning: Group A (2.5 mg/ml), Group B (5 mg/ml), and Group C (10 mg/ml) by different concentrations of KH902 eye drops and Group D by saline solution as control with three times a day for 2 weeks. At days 7, 14, and 28, the anterior segment photographs, confocal microscopy, and histopathology were performed to evaluate corneal opacity, neovascularization, inflammatory cell density, vessel size, and edema. Immunohistochemistry was applied to analyze the vascular endothelial growth factor (VEGF) level.

RESULTS

(1) The CNV in the medicine-treated groups showed a reduction without obvious corneal side effects histologically. (2) Compared to the control group, the three medicine-treated groups showed a reduction in the VEGF levels and CNV areas on days 7, 14, and 28 and in the inflammatory cell density on days 14 and 28 (P < 0.01). The difference of inflammatory cell density between the three medicine-treated groups existed on day 14 (P < 0.01). There were differences in the VEGF levels between Groups A, B, and C on days 7, 14, and 28 (P < 0.01), not for Groups B and C on day 28 (P > 0.05).

CONCLUSION

KH902 eye drops in lower concentration showed an obvious reduction of the CNV growing for rabbit corneal alkali burn without side effects.

摘要

目的

本研究旨在评估不同浓度的KH902滴眼液对碱烧伤诱导的兔角膜新生血管化(CNV)的抑制作用。

方法

48只成年兔碱烧伤后随机分为四组:A组(2.5mg/ml)、B组(5mg/ml)和C组(10mg/ml),分别给予不同浓度的KH902滴眼液,D组给予生理盐水作为对照,每天滴眼3次,共2周。在第7、14和28天,进行眼前节照相、共聚焦显微镜检查和组织病理学检查,以评估角膜混浊、新生血管化、炎症细胞密度、血管大小和水肿情况。应用免疫组织化学分析血管内皮生长因子(VEGF)水平。

结果

(1)药物治疗组的CNV在组织学上显示减少,且无明显角膜副作用。(2)与对照组相比,三个药物治疗组在第7、14和28天的VEGF水平和CNV面积以及在第14和28天的炎症细胞密度均降低(P<0.01)。三个药物治疗组在第14天的炎症细胞密度存在差异(P<0.01)。A、B、C组在第7、14和28天的VEGF水平存在差异(P<0.01),B组和C组在第28天无差异(P>0.05)。

结论

低浓度的KH902滴眼液可明显减少兔角膜碱烧伤后CNV的生长,且无副作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/ab7e448d4af7/IJO-65-1127-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/bca0c07eb51d/IJO-65-1127-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/cf964e7751f7/IJO-65-1127-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/11479dfe511d/IJO-65-1127-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/576b7580fb81/IJO-65-1127-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/a3bea9335260/IJO-65-1127-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/e507e9ba72d1/IJO-65-1127-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/ab7e448d4af7/IJO-65-1127-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/bca0c07eb51d/IJO-65-1127-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/cf964e7751f7/IJO-65-1127-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/11479dfe511d/IJO-65-1127-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/576b7580fb81/IJO-65-1127-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/a3bea9335260/IJO-65-1127-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/e507e9ba72d1/IJO-65-1127-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc19/5700579/ab7e448d4af7/IJO-65-1127-g007.jpg

相似文献

1
The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn.不同浓度KH902滴眼液对碱烧伤诱导的角膜新生血管的抑制作用。
Indian J Ophthalmol. 2017 Nov;65(11):1127-1132. doi: 10.4103/ijo.IJO_339_17.
2
KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.KH902,一种重组人 VEGF 受体融合蛋白,降低了碱烧伤诱导的角膜新生血管中胎盘生长因子的水平。
Ophthalmic Res. 2013;50(3):180-6. doi: 10.1159/000353437. Epub 2013 Sep 4.
3
Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.纤溶酶原kringle 5抑制碱烧伤诱导的角膜新生血管形成。
Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4062-71. doi: 10.1167/iovs.04-1330.
4
Inhibitory effect of sub-conjunctival tocilizumab on alkali burn induced corneal neovascularization in rats.结膜下注射托珠单抗对大鼠碱烧伤诱导的角膜新生血管形成的抑制作用。
Curr Eye Res. 2015 Jan;40(1):48-55. doi: 10.3109/02713683.2014.914541. Epub 2014 Jun 9.
5
The effect of TC14012 on alkali burn-induced corneal neovascularization in mice.TC14012 对小鼠碱烧伤诱导的角膜新生血管的作用。
Ophthalmic Res. 2014;52(1):17-24. doi: 10.1159/000358201. Epub 2014 May 14.
6
Naringenin Eye Drops Inhibit Corneal Neovascularization by Anti-Inflammatory and Antioxidant Mechanisms.柚皮素滴眼液通过抗炎和抗氧化机制抑制角膜新生血管形成。
Invest Ophthalmol Vis Sci. 2017 Nov 1;58(13):5764-5776. doi: 10.1167/iovs.16-19702.
7
KH906, a recombinant human VEGF receptor fusion protein, is a new effective topical treatment for corneal neovascularization.KH906是一种重组人血管内皮生长因子受体融合蛋白,是一种治疗角膜新生血管的新型有效局部用药。
Mol Vis. 2011 Mar 25;17:797-803.
8
The wound healing effects of vitamin A eye drops after a corneal alkali burn in rats.维生素 A 滴眼液对大鼠角膜碱烧伤后伤口愈合的影响。
Acta Ophthalmol. 2012 Nov;90(7):e540-6. doi: 10.1111/j.1755-3768.2012.02496.x.
9
NK1 receptor antagonists as a new treatment for corneal neovascularization.NK1受体拮抗剂作为角膜新生血管化的一种新疗法。
Invest Ophthalmol Vis Sci. 2014 Sep 16;55(10):6783-94. doi: 10.1167/iovs.14-14553.
10
Inhibitory effects of gene silencing on alkali burn-induced corneal neovascularization: an in vivo study.基因沉默对碱烧伤诱导的角膜新生血管形成的抑制作用:一项体内研究。
Mol Vis. 2017 Apr 26;23:286-295. eCollection 2017.

引用本文的文献

1
Physiologically based pharmacokinetic models for systemic disposition of protein therapeutics in rabbits.基于生理学的兔体内蛋白质治疗药物全身处置的药代动力学模型。
Front Pharmacol. 2024 Aug 28;15:1427325. doi: 10.3389/fphar.2024.1427325. eCollection 2024.
2
Efficacious, safe, and stable inhibition of corneal neovascularization by AAV-vectored anti-VEGF therapeutics.通过腺相关病毒载体抗血管内皮生长因子疗法有效、安全且稳定地抑制角膜新生血管形成。
Mol Ther Methods Clin Dev. 2021 Jun 24;22:107-121. doi: 10.1016/j.omtm.2021.06.007. eCollection 2021 Sep 10.
3
Effects of VEGF Inhibitor Conbercept on Corneal Neovascularization Following Penetrating Keratoplasty in Rabbit Model.

本文引用的文献

1
INTRAVITREAL CONBERCEPT (KH902) FOR SURGICAL TREATMENT OF SEVERE PROLIFERATIVE DIABETIC RETINOPATHY.玻璃体内注射康柏西普(KH902)用于严重增殖性糖尿病视网膜病变的手术治疗
Retina. 2016 May;36(5):938-43. doi: 10.1097/IAE.0000000000000900.
2
Comparison of the effects of subconjunctival and topical anti-VEGF therapy (bevacizumab) on experimental corneal neovascularization.结膜下注射与局部应用抗血管内皮生长因子疗法(贝伐单抗)对实验性角膜新生血管形成的效果比较。
Arq Bras Oftalmol. 2014 Aug;77(4):209-13. doi: 10.5935/0004-2749.20140054.
3
[Effect of KH902 in inhibiting suture induced corneal neovascularization].
血管内皮生长因子抑制剂康柏西普对兔穿透性角膜移植术后角膜新生血管形成的影响
Clin Ophthalmol. 2020 Jul 31;14:2185-2193. doi: 10.2147/OPTH.S260302. eCollection 2020.
KH902对抑制缝线诱导角膜新生血管形成的作用
Sichuan Da Xue Xue Bao Yi Xue Ban. 2014 May;45(3):419-23.
4
Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study.康柏西普治疗新生血管性年龄相关性黄斑变性的安全性和有效性:一项为期 12 个月的随机 2 期研究结果:AURORA 研究。
Ophthalmology. 2014 Sep;121(9):1740-7. doi: 10.1016/j.ophtha.2014.03.026. Epub 2014 May 1.
5
Anti-VEGF therapy (bevacizumab) for sulfur mustard-induced corneal neovascularization associated with delayed limbal stem cell deficiency in rabbits.抗血管内皮生长因子疗法(贝伐单抗)治疗兔芥子气诱导的角膜新生血管化伴延迟性角膜缘干细胞缺乏症
Curr Eye Res. 2014 May;39(5):439-50. doi: 10.3109/02713683.2013.850098. Epub 2013 Nov 11.
6
KH902, a recombinant human VEGF receptor fusion protein, reduced the level of placental growth factor in alkali burn induced-corneal neovascularization.KH902,一种重组人 VEGF 受体融合蛋白,降低了碱烧伤诱导的角膜新生血管中胎盘生长因子的水平。
Ophthalmic Res. 2013;50(3):180-6. doi: 10.1159/000353437. Epub 2013 Sep 4.
7
Anti-angiogenic effect of KH902 on retinal neovascularization.KH902 对视网膜新生血管的抗血管生成作用。
Graefes Arch Clin Exp Ophthalmol. 2013 Sep;251(9):2131-9. doi: 10.1007/s00417-013-2392-6. Epub 2013 Jun 6.
8
Corneal neovascularization: an anti-VEGF therapy review.角膜新生血管:抗血管内皮生长因子治疗综述。
Surv Ophthalmol. 2012 Sep;57(5):415-29. doi: 10.1016/j.survophthal.2012.01.007.
9
A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis.一种新型的人载脂蛋白 E 衍生肽是一种肿瘤生长和眼部血管生成的抑制剂。
PLoS One. 2011 Jan 6;6(1):e15905. doi: 10.1371/journal.pone.0015905.
10
A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration.一项 KH902(一种血管内皮生长因子受体诱饵)治疗渗出性年龄相关性黄斑变性的 1 期研究。
Ophthalmology. 2011 Apr;118(4):672-8. doi: 10.1016/j.ophtha.2010.08.008. Epub 2010 Dec 13.